Healthpeak Properties (NYSE:PEAK – Get Rating) had its price target increased by Morgan Stanley from $26.00 to $27.00 in a report released on Wednesday, Marketbeat Ratings reports. They currently have an equal weight rating on the stock.
Several other research analysts have also recently commented on the company. Citigroup upgraded Healthpeak Properties from a neutral rating to a buy rating and cut their price target for the stock from $33.00 to $31.00 in a research note on Friday, July 8th. Jefferies Financial Group reduced their price objective on Healthpeak Properties from $33.00 to $26.00 and set a hold rating for the company in a research report on Thursday, June 30th. Evercore ISI set a $32.00 price objective on Healthpeak Properties in a research report on Monday, June 20th. Mizuho reduced their price objective on Healthpeak Properties from $37.00 to $29.00 and set a neutral rating for the company in a research report on Friday, July 29th. Finally, Capital One Financial assumed coverage on Healthpeak Properties in a research report on Friday, June 3rd. They set an equal weight rating and a $34.00 price objective for the company. Seven investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of Hold and an average price target of $33.18.
Healthpeak Properties Trading Down 0.2 %
Shares of PEAK opened at $26.25 on Wednesday. The company has a debt-to-equity ratio of 0.94, a current ratio of 0.83 and a quick ratio of 0.83. Healthpeak Properties has a 12 month low of $23.23 and a 12 month high of $36.85. The stock’s 50-day moving average is $26.84 and its two-hundred day moving average is $29.84. The stock has a market cap of $14.16 billion, a PE ratio of 64.03, a P/E/G ratio of 3.43 and a beta of 0.78.
Healthpeak Properties Dividend Announcement
Hedge Funds Weigh In On Healthpeak Properties
Hedge funds have recently modified their holdings of the stock. abrdn plc increased its position in Healthpeak Properties by 2.1% during the fourth quarter. abrdn plc now owns 443,042 shares of the company’s stock worth $15,989,000 after buying an additional 9,097 shares during the last quarter. First Trust Advisors LP boosted its holdings in Healthpeak Properties by 30.8% during the fourth quarter. First Trust Advisors LP now owns 299,884 shares of the company’s stock valued at $10,823,000 after acquiring an additional 70,537 shares during the period. Mirae Asset Global Investments Co. Ltd. boosted its holdings in Healthpeak Properties by 27.5% during the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 44,296 shares of the company’s stock valued at $1,599,000 after acquiring an additional 9,552 shares during the period. Raymond James & Associates boosted its holdings in Healthpeak Properties by 1.2% during the fourth quarter. Raymond James & Associates now owns 441,061 shares of the company’s stock valued at $15,918,000 after acquiring an additional 5,153 shares during the period. Finally, Steward Partners Investment Advisory LLC boosted its holdings in Healthpeak Properties by 20.6% during the fourth quarter. Steward Partners Investment Advisory LLC now owns 3,272 shares of the company’s stock valued at $118,000 after acquiring an additional 560 shares during the period. 95.24% of the stock is owned by institutional investors and hedge funds.
About Healthpeak Properties
Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns and develops high-quality real estate in the three private-pay healthcare asset classes of Life Science, Medical Office and Senior Housing, designed to provide stability through the inevitable industry cycles.
- Get a free copy of the StockNews.com research report on Healthpeak Properties (PEAK)
- Can Alibaba And Baidu Finally Rally With Delisting Fears Gone?
- Is World Wresting Entertainment Getting Ready to Be Sold?
- 3 Materials Stocks That May Earn a Place on Your Watchlist
- Crowdstrike Stock Retraces, As Earnings Sober Expectations
- Will The Institutions Buy The Dip In Ambarella Stock?
Receive News & Ratings for Healthpeak Properties Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthpeak Properties and related companies with MarketBeat.com's FREE daily email newsletter.